Tuesday, January 14, 2014 2:15:33 PM
New technology in cardiovascular LDL-P is the breakthrough technology that all labs will be using in the future. Doctors are beginning to be educated about the how the old LDL-C test is going to be obsolete. Medical technology advances are what make markets move.
Quest Diagnosics needs this technology. DGX 92.00 PPS
LPDX already has 51,000,000 revenues and 50,000,000 cash. Only trading in a float of 10,000,000.
As the restructuring of research and development costs decline the contract/sales for this technology will grow internationally.
Recent news regarding Scripps out of California is just the beginning.
ENJOY THE RIDE!!!!!!! The volume will through this crazy above 100 and vaporize the float with a real company new technology already making millions in a niche market...
SMILING @ 100+
http://www.liposcience.com/about-liposcience/our-technology
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM